Charles River Laboratories (CRL)
Payables turnover
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Cost of revenue | US$ in thousands | 962,393 | 827,224 | 759,312 | 662,852 | 627,506 |
Payables | US$ in thousands | 168,937 | 205,915 | 198,130 | 122,475 | 111,498 |
Payables turnover | 5.70 | 4.02 | 3.83 | 5.41 | 5.63 |
December 31, 2023 calculation
Payables turnover = Cost of revenue ÷ Payables
= $962,393K ÷ $168,937K
= 5.70
The payables turnover ratio for Charles River Laboratories has varied over the past five years, indicating the company's efficiency in managing its accounts payable. In 2023, the payables turnover ratio increased to 5.70 from 4.02 in 2022, which suggests that the company is paying its suppliers more frequently within the year. This could signify improved liquidity or negotiation terms with suppliers.
Comparing to the previous years, the payables turnover ratio was 3.83 in 2021, 5.41 in 2020, and 5.63 in 2019. The fluctuation in the ratio over the years could be due to changes in payment terms or the company's overall financial performance. Overall, a higher payables turnover ratio indicates better management of payables, but it is essential to consider other factors such as industry standards and company-specific circumstances when interpreting this ratio.
Peer comparison
Dec 31, 2023